touchOPTHALMOLOGY spoke to Christine Kay at AAO 2018 regarding her long-running course titled ‘Retinal Frontiers: Updates in Gene Therapy and Stem Cell Therapy’, as well as her most exciting advances and trials in gene and stem cell therapy and her key highlights from this year’s meeting.
1. Please tell us about your course at this year’s AAO meeting, ‘Retinal Frontiers: Updates in Gene Therapy and Stem Cell Therapy’. (0:11)
2. What do you think is the most exciting upcoming advance or trial in gene and stem cell therapy? (1:58)
3. What are your key highlights from this year’s AAO meeting? (3:26)
Speaker disclosures: Christine Nichols Kay is a consultant for Spark Therapeutics, an investigator for Alkeus and Foundation for Fighting Blindness and a consultant/investigator for AGTC.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Retina/Vitreous
J Fernando Arevalo, AAO 2020 – Intravitreal Anti-VEGF Injections for Exudative Retinal Arterial Macroaneurysms
It was a pleasure to catch up with our valued Editorial Board member, J Fernando Arevalo (Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA), who gave his insights on his topic at the retina subspecialty day at AAO 2020, intravitreal anti-VEGF injections for exudative retinal arterial macroaneurysms. Questions Could you give […]
Tommaso Rossi, EURETINA 2020 – Novel Instrument for Internal Limiting Membrane
We were delighted to catch up with Prof. Tommaso Rossi, who talked us through his presentation at EURETINA 2020 concerning a novel instrument for internal limiting membrane, amniotic and retinal flap manipulation. Questions What is the rationale for the use of amniotic membrane grafts in vitreoretinal surgery, and in what ophthalmic indications are they used? […]
Peter Stalmans, EURETINA 2020 – End-stage Retinitis Pigmentosa Patients Implanted with 3D–neural Interface Retinal Prosthesis
Prof. Peter Stalmans (University Hospitals, Leuven, Belgium) talked us through his presentation at EURETINA on first reported clinical results from end-stage retinitis pigmentosa patients implanted with an innovative 3D neural interface retinal prosthesis. Questions Could you give us an overview of advances in retinal prosthesis approaches in the treatment of advanced retinitis pigmentosa […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!